当前位置:首页 - 行情中心 - 柳药集团(603368) - 财务分析 - 现金流量表

柳药集团

(603368)

  

流通市值:60.30亿  总市值:60.30亿
流通股本:3.97亿   总股本:3.97亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金11,281,046,091.65,114,428,851.0223,951,747,424.0917,721,996,751.87
  收到的税费返还566,752.38270,025.14141,7003,848,023.88
  收到其他与经营活动有关的现金158,590,819.47296,729,929.86222,098,388.78241,095,290.59
  经营活动现金流入小计11,440,203,663.455,411,428,806.0224,173,987,512.8717,966,940,066.34
  购买商品、接受劳务支付的现金10,145,935,124.725,269,408,882.2621,280,290,272.2216,171,496,988.66
  支付给职工以及为职工支付的现金301,196,582.87166,305,450.54541,468,937.7413,302,973.44
  支付的各项税费329,320,694.62153,315,944.39513,423,706.54379,929,699.02
  支付其他与经营活动有关的现金528,224,046.32331,550,095.92761,145,667.05866,820,735.23
  经营活动现金流出小计11,304,676,448.535,920,580,373.1123,096,328,583.5117,831,550,396.35
  经营活动产生的现金流量净额135,527,214.92-509,151,567.091,077,658,929.36135,389,669.99
二、投资活动产生的现金流量:
  收回投资收到的现金--76,522,30052,022,300
  取得投资收益收到的现金434,574.75-38,237,596.2120,770,790.66
  处置固定资产、无形资产和其他长期资产收回的现金净额87,536.0923,841.9422,249.12486,468.12
  收到的其他与投资活动有关的现金1,055,000,000225,000,0001,130,000,000415,760,000
  投资活动现金流入小计1,055,522,110.84225,023,841.91,245,182,145.33489,039,558.78
  购建固定资产、无形资产和其他长期资产支付的现金70,792,383.6845,186,035.67184,491,418.56124,158,855.75
  投资支付的现金300,000-517,536,118.89516,494,656.74
  支付其他与投资活动有关的现金880,000,000329,451,408.351,045,000,000450,000,000
  投资活动现金流出小计951,092,383.68374,637,444.021,747,027,537.451,090,653,512.49
  投资活动产生的现金流量净额104,429,727.16-149,613,602.12-501,845,392.12-601,613,953.71
三、筹资活动产生的现金流量:
  取得借款收到的现金1,945,067,261.711,565,067,261.713,509,137,583.542,706,979,560.19
  收到其他与筹资活动有关的现金2,278,881,413.29522,702,207.143,083,121,466.78923,735,028.35
  筹资活动现金流入小计4,223,948,6752,087,769,468.856,592,259,050.323,630,714,588.54
  偿还债务支付的现金1,935,568,000937,750,0003,317,149,718.682,226,371,236.25
  分配股利、利润或偿付利息支付的现金405,577,383.55603,939,115.7459,966,347.82434,464,174.59
  其中:子公司支付给少数股东的股利、利润5,807,976.285,807,976.2810,444,7168,570,826
  支付其他与筹资活动有关的现金2,492,816,922.511,428,556,792.493,447,209,869.872,249,208,429.41
  筹资活动现金流出小计4,833,962,306.062,970,245,908.197,224,325,936.374,910,043,840.25
  筹资活动产生的现金流量净额-610,013,631.06-882,476,439.34-632,066,886.05-1,279,329,251.71
五、现金及现金等价物净增加额-370,056,688.98-1,541,241,608.55-56,253,348.81-1,745,553,535.43
  加:期初现金及现金等价物余额3,342,307,715.413,342,307,715.413,398,561,064.223,398,561,064.22
  期末现金及现金等价物余额2,972,251,026.431,801,066,106.863,342,307,715.411,653,007,528.79
补充资料:
  净利润371,359,675.49-720,536,392.03-
  资产减值准备--14,201,258.09-
  固定资产和投资性房地产折旧42,628,504.89-82,192,428.23-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧42,628,504.89-82,192,428.23-
  无形资产摊销8,857,773.5-18,833,107.18-
  长期待摊费用摊销9,365,912.21-21,990,385.81-
  处置固定资产、无形资产和其他长期资产的损失259,646.16--241,629.05-
  固定资产报废损失875,680.74-349,493.59-
  财务费用64,294,185.85-210,286,224.26-
  投资损失-1,107,451.3-52,357.96-
  递延所得税-4,861,332.37--24,960,624.94-
  其中:递延所得税资产减少-7,098,812.71--18,210,384.68-
    递延所得税负债增加2,237,480.34--6,750,240.26-
  存货的减少-183,223,380.23--338,111,563.77-
  经营性应收项目的减少327,611,346.83-1,488,148,099.38-
  经营性应付项目的增加-554,394,272.48--1,243,943,338.93-
  其他-1,094,531.46--4,280,840.03-
  现金的期末余额2,972,251,026.43-3,342,307,715.41-
  减:现金的期初余额3,342,307,715.41-3,398,561,064.22-
  现金及现金等价物的净增加额-370,056,688.98--56,253,348.81-
公告日期2026-08-282026-04-302026-04-302025-10-30
审计意见(境内)标准无保留意见
TOP↑